Arnatar Therapeutics
Arnatar Therapeutics raises $52M Series A
Quick Facts
Arnatar Therapeutics: Series A Funding Round
Arnatar Therapeutics has successfully raised $52M in Series A funding.
Company Overview
Developing therapeutics for autoimmune and inflammatory diseases
Funding Details
The Series A round was led by Eight Roads and 3E Bioventures.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2022
- Employees: 45+
- Category: HealthTech
Investment
Arnatar Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Eight Roads and 3E Bioventures: Verified investor in Series A
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
